Get started Log in

POLX — Polarean Imaging Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Market Cap
£1.21m
Enterprise Value
-£3.90m
Revenue
$3.09m

FDA grants New Chemical Entity designation
01/02/2023 16:25
Block listing six monthly return
27/01/2023 07:00
Brief: FDA Approves Polarean's Xenoview For Use With MRI For The Evaluation Of Lung Ventilation
28/12/2022 13:05
Second Price Monitoring Extn
28/12/2022 09:05
Price Monitoring Extension
28/12/2022 09:00
Brief: Polarean Imaging Says FDA Approves Co's Xenoview
28/12/2022 07:16
FDA Approves XENOVIEW™ (Xe 129 hyperpolarized)
28/12/2022 07:00
Second Price Monitoring Extn
03/10/2022 11:05
Price Monitoring Extension
03/10/2022 11:00
Update on New Drug Application
30/09/2022 07:00
Second Price Monitoring Extn
22/09/2022 14:05
Price Monitoring Extension
22/09/2022 14:00
Second Price Monitoring Extn
22/09/2022 11:06
Price Monitoring Extension
22/09/2022 11:00
Second Price Monitoring Extn
22/09/2022 09:05
Price Monitoring Extension
22/09/2022 09:00
Brief: Polarean Imaging Says FDA Requested For Additional Information
22/09/2022 07:28
Update on New Drug Application
22/09/2022 07:04
Brief: Polarean Imaging HY Revenue $834,087
31/08/2022 07:17
Half-year Report
31/08/2022 07:00